Biotech | June 10, 2022
Bayer’s Vividion emerging as significant player in San Diego Biotech hub
Bayer now present in four of the largest biotechnology hubs in the United States
Bayer now present in four of the largest biotechnology hubs in the United States
The rally attracted around 250 riders, including professionals and amateurs.
The company’s annual sales grew from Rs 548.12 crore in FY 2020-21 to Rs 598.65 crore this fiscal
The centre works with active pharmaceutical ingredients (APIs) and can utilize innovative concepts with model APIs
Includes thermostabilized Ebola vaccines
When asked how to balance ESG with broader business goals, the panel was unanimous in its assessment that ESG is ‘good for business’
Moderna continues to expand its mRNA platform for a range of additional clinical applications and routes of administration including a modality for lung delivery
The study will evaluate the effectiveness of Nantheia ATL5, an investigational drug using cannabidiol in ANANDA’s proprietary delivery technology
AKS-452 is currently undergoing Phase II/III clinical testing in India as a primary vaccine; submission for Emergency Use Authorization (EUA) expected by Q3 2022
CB03 is a candidate drug for the treatment of refractory epilepsy, independently developed by Zhimeng
Subscribe To Our Newsletter & Stay Updated
